Yahoo
OTC Markets OTCQB USD

Biotricity, Inc. (BTCY)

0.0600 +0.0040 (+7.14%)
At close: November 10 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
16,401.2020 15,998.2390 13,790.2940 12,063.3450 9,639.0570
Cost of Revenue
-3,038.3840 -3,049.4410 -3,225.8030 -3,707.0640 -4,197.0240
Gross Profit
13,362.8180 12,948.7980 10,564.4910 8,356.2810 5,442.0330
Selling, General and Administrative Expenses
-9,053.9810 -8,493.3650 -10,857.7970 -14,612.7240 -17,621.8650
Research and Development Expenses
-2,741.4780 -2,764.1970 -2,155.6600 -2,571.8260 -3,229.8790
Operating Income/Expenses
-11,795.4590 -11,257.5620 -13,013.4570 -17,184.5500 -20,851.7440
Total Operating Profit/Loss
1,567.3590 1,691.2360 -2,448.9660 -8,828.2690 -15,409.7110
Total Net Finance Income/Expense
-4,152.4090 -4,107.8460 -5,201.8540 -5,191.7230 -2,582.6180
Net Investment Income
-252.2000 -167.3490 -553.8560 9.7770 -483.8730
Other Income/Expense, Non-Operating
145.6200 179.8200 -216.5030 -84.0680 -181.9410
Non-Operating Income/Expenses, Total
-4,258.9890 -4,095.3750 -5,972.2130 -5,266.0140 -3,248.4320
Pretax Income
-2,691.6300 -2,404.1390 -8,421.1790 -14,094.2830 -18,658.1430
Provision for Income Tax
0 0 0 0 0
Net Income from Continuing Operations
-2,691.6300 -2,404.1390 -8,421.1790 -14,094.2830 -18,658.1430
Net Income after Extraordinary Items and Discontinued Operations
-2,691.6300 -2,404.1390 -8,421.1790 -14,094.2830 -18,658.1430
Net Income after Non-Controlling/Minority Interests
-2,691.6300 -2,404.1390 -8,421.1790 -14,094.2830 -18,658.1430
Preferred/Other Stock Distribution
-752.8450 -724.3190 -3,520.8210 -834.6770 -875.5400
Net Income Available to Common Stockholders
-3,444.4750 -3,128.4580 -11,942 -14,928.9600 -19,533.6830
Diluted Net Income Available to Common Stockholders
-3,444.4750 -3,128.4580 -11,942 -14,928.9600 -19,533.6830
Basic EPS
-0.13 -0.12 -0.56 -1.66 -2.26
Diluted EPS
-0.13 -0.12 -0.56 -1.66 -2.26
Basic Weighted Average Shares Outstanding
26,507.2270 27,304.3170 21,524.8840 8,991.7660 8,659.7180
Diluted Weighted Average Shares Outstanding
26,507.2270 27,304.3170 21,524.8840 8,991.7660 8,659.7180
Reported Normalized Basic EPS
0.06 0.06 -0.05 -0.87 -1.70
Reported Normalized Diluted EPS
0.06 0.06 -0.05 -0.87 -1.70
Income Statement, Supplemental
EBIT
1,460.7790 1,703.7070 -3,219.3250 -8,902.5600 -16,075.5250
EBITDA
1,466.7320 1,709.6600 -3,213.3720 -8,896.6070 -16,069.5720
Normalized EBITDA
2,222.3480 1,722.8210 -981.3150 -7,796.3860 -14,757.6150
Normalized Income
-2,079.7630 -2,211.1580 -6,405.6250 -13,078.1300 -17,526.6390
3/31/2023 - 2/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: